39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial
ContributorsKoenig, Christa; Bodmer, Nicole; Agyeman, Philipp K A; Niggli, Felix; Adam, Cécile; Ansari Djaberi, Marc Georges; Eisenreich, Bernhard; Keller, Nanette; Leibundgut, Kurt; Nadal, David; Roessler, Jochen; Scheinemann, Katrin; Simon, Arne; Teuffel, Oliver; von der Weid, Nicolas X; Zeller, Michael; Zimmermann, Karin; Ammann, Roland A
Published inThe Lancet. Child & adolescent health., vol. 4, no. 7, p. 495-502
Publication date2020-07
First online date2020-06-01
Abstract
Keywords
- Adolescent
- Antineoplastic Agents / therapeutic use
- Bacteremia / epidemiology
- Body Temperature
- Child
- Child, Preschool
- Cross-Over Studies
- Ear
- Febrile Neutropenia / diagnosis
- Female
- Humans
- Intensive Care Units, Pediatric
- Male
- Neoplasms / therapy
- Patient Admission / statistics & numerical data
- Prospective Studies
- Sepsis / epidemiology
Affiliation entities
Research groups
Funding
- Swiss Cancer League [KLS-3645-02-2015]
Citation (ISO format)
KOENIG, Christa et al. 39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial. In: The Lancet. Child & adolescent health., 2020, vol. 4, n° 7, p. 495–502. doi: 10.1016/S2352-4642(20)30092-4
Main files (1)
Article (Published version)
Identifiers
- PID : unige:158619
- DOI : 10.1016/S2352-4642(20)30092-4
- PMID : 32497520
Journal ISSN2352-4642
